NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis $4.49 -0.02 (-0.44%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$4.50 +0.01 (+0.33%) As of 09/25/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Clover Health Investments Stock (NASDAQ:CLOV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CLOV alerts:Sign Up Key Stats Today's Range$4.47▼$4.6750-Day Range$4.10▼$5.1052-Week Range$1.58▼$5.59Volume3.60 million shsAverage Volume4.05 million shsMarket Capitalization$2.38 billionP/E RatioN/ADividend YieldN/APrice Target$4.75Consensus RatingHold Company Overview Clover Health Investments, Inc. is a healthcare technology and insurance company focused on providing Medicare Advantage plans to eligible Medicare beneficiaries. Its insurance business offers medical coverage and related healthcare benefits through plans available in select counties across the United States. The company also develops and uses Clover Assistant, a technology platform designed to support physicians with patient information, clinical insights, care recommendations and tools intended to help improve healthcare outcomes. Clover uses data and software to assist providers in managing the needs of Medicare Advantage members and coordinating care. Clover Health was founded in 2012 and became a publicly traded company in January 2021 through a merger with a special purpose acquisition company. Andrew Toy serves as the company's chief executive officer. The company continues to focus on combining Medicare Advantage insurance with technology-enabled healthcare services.AI Generated. May Contain Errors. Read More Clover Health Investments Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreCLOV MarketRank™: Clover Health Investments scored higher than 50% of companies evaluated by MarketBeat, and ranked 533rd out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingHold Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Clover Health Investments is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageClover Health Investments has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Clover Health Investments' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth183.33% Earnings GrowthEarnings for Clover Health Investments are expected to grow by 183.33% in the coming year, from $0.06 to $0.17 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -89.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -89.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 7.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Clover Health Investments' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.77% of the float of Clover Health Investments has been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 5.18.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 0.98%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.44 News SentimentClover Health Investments has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Clover Health Investments this week, compared to 5 articles on an average week.Search InterestOnly 8 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -73% compared to the previous 30 days.MarketBeat Follows7 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,642,586.00 in company stock.Percentage Held by Insiders23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Stock News HeadlinesClover Health Investments, Corp. Appoints Robert Torricelli and Dr. Brian J. Miller to the Board of Directors, Effective September 24, 2026September 24 at 12:16 AM | marketscreener.comMClover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of DirectorsSeptember 24 at 7:15 PM | markets.businessinsider.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of DirectorsSeptember 24 at 7:15 PM | finance.yahoo.comUPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D.September 24 at 5:55 PM | globenewswire.comClover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D.September 24 at 4:30 PM | globenewswire.comInsider Selling: Clover Health Investments (NASDAQ:CLOV) VP Sells $14,708.80 in StockSeptember 18, 2026 | insidertrades.comClover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 6,846 SharesSeptember 16, 2026 | insidertrades.comSee More Headlines CLOV Stock Analysis - Frequently Asked Questions How have CLOV shares performed this year? Clover Health Investments' stock was trading at $2.35 at the beginning of 2026. Since then, CLOV shares have increased by 91.1% and is now trading at $4.49. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) released its quarterly earnings results on Wednesday, August, 5th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.01. The business earned $743.17 million during the quarter, compared to analyst estimates of $728.27 million. Clover Health Investments had a negative net margin of 0.74% and a negative trailing twelve-month return on equity of 4.20%. Read the conference call transcript. Who are Clover Health Investments' major shareholders? Clover Health Investments' top institutional shareholders include Bank of New York Mellon Corp (0.23%), California State Teachers Retirement System (0.09%), Tidal Investments LLC (0.08%) and WINTON GROUP Ltd (0.03%). Insiders that own company stock include Andrew Toy, Brady Patrick Priest, Karen Soares, Conrad Wai, Carladenise Armbrister Edwards, Joseph Frank Oldakowski and Anna U Loengard. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Clover Health Investments own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA). Company Calendar Last Earnings8/05/2026Today9/26/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 CLOV's financial health is in the Green zone, according to TradeSmith. CLOV has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNASDAQ:CLOV CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees724Year Founded2014Price Target and Rating Average Price Target for Clover Health Investments$4.75 High Price Target$6.00 Low Price Target$2.50 Potential Upside/Downside+5.8%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.05) Trailing P/E RatioN/A Forward P/E Ratio74.83 P/E GrowthN/ANet Income-$85.55 million Net Margins-0.74% Pretax Margin-0.74% Return on Equity-4.20% Return on Assets-2.28% Debt Debt-to-Equity RatioN/A Current Ratio1.50 Quick Ratio1.50 Sales & Book Value Annual Sales$2.48 billion Price / Sales0.96 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book7.61Miscellaneous Outstanding Shares531,156,000Free Float406,281,000Market Cap$2.38 billion OptionableOptionable Beta2.47 Social Links 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:CLOV) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLOV Stock Alerts